Clinical observational study of bacteriophage therapy in skin and soft tissue infections in georgia

Closed Pre-Solicitation Posted

Not the latest version. See the latest special notice from .

Solicitation number
W81XWH22Q0022RFI
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Tibilisi Georgia

Notice details come from SAM.gov. Updated .

About this opportunity

Written by GovTribe AI ·

The Department of the Army Medical Command seeks capability statements to support a clinical observational study of bacteriophage therapy in skin and soft tissue infections in Georgia. The study will be conducted by the Medical Research Development Command to identify treatments for combat wound infections and sepsis. Respondents must provide study personnel meeting regulatory requirements, provide updates on patient enrollment and sample transfers, ensure personnel receive protocol training, and conduct testing and sample logging according to the protocol. Responses are due by February 7, 2022 and shall not exceed three pages in 12-point font.

There is no set-aside designation. The NAICS and PSC codes were not provided. Award values or budgets were not included. The contractor must provide an unspecified quantity of study personnel and conduct testing, sample collection and transfers, and training according to the medical research protocol's timeline and requirements.

Notice text

Please see attached Sources Sought document

Files

File Type Posted
A02 Request for Information WRAIR.pdf PDF

Notice history

Notice Type Posted
Clinical observational study of bacteriophage therapy in skin and soft tissue infections in georgia Latest special notice Special Notice
This notice Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login

GovTribe for Federal Contractors